Who qualifies for GLP-1 weight-loss medication?

The standard gates (Wegovy, Zepbound, Saxenda labels): - BMI ≥ 30 — qualifies on its own; or - BMI ≥ 27 with at least one comorbidity — hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, or cardiovascular disease. - Adolescents 12+ qualify under separate pediatric criteria (Wegovy, Saxenda) with specialist involvement. Beyond the label, licensed clinicians can and do prescribe off-label where the clinical logic supports it — common examples include BMI ≥ 27 without a formal comorbidity, BMI ≥ 25 with comorbidities, or relapse-prevention in people with a documented obesity history who have lost weight (the microdosing context). Off-label is legal and routine in medicine; the responsible versions are documented, screened, and reasoned — not rubber-stamped. Disqualifiers that override everything: - Personal/family history of medullary thyroid carcinoma or MEN 2 (why) - Pregnancy, breastfeeding, or active trying (details) - History of pancreatitis; active gallbladder disease; severe GI disease/gastroparesis - Active eating disorder - BMI < 18.5, and “cosmetic” weight loss generally (why programs say no) What a real qualification process looks like (in person or telehealth): full health history and medication review, the screens above, baseline weight/BP/heart rate, sometimes labs, and ID verification for controlled processes. A program that “qualifies” you with five clicks and no human review isn’t lowering the bar for your convenience — it’s telling you nobody is responsible for your safety. See is telehealth legit?